Lisdexamfetamine dimesylate: the first prodrug stimulant.
about
Potential adverse effects of amphetamine treatment on brain and behavior: a reviewClinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsUpdate on optimal use of lisdexamfetamine in the treatment of ADHD.A post hoc comparison of the effects of lisdexamfetamine dimesylate and osmotic-release oral system methylphenidate on symptoms of attention-deficit hyperactivity disorder in children and adolescents.An Infant with a Prolonged Sympathomimetic Toxidrome after Lisdexamfetamine Dimesylate Ingestion.
P2860
Lisdexamfetamine dimesylate: the first prodrug stimulant.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@ast
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@en
type
label
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@ast
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@en
prefLabel
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@ast
Lisdexamfetamine dimesylate: the first prodrug stimulant.
@en
P2860
P1433
P1476
Lisdexamfetamine dimesylate: the first prodrug stimulant
@en
P2093
David W Goodman
P2860
P577
2007-08-01T00:00:00Z